Insulet (PODD) Share-based Compensation (2010 - 2026)
Insulet's (PODD) quarterly Share-based Compensation came in at $15.7 million in Q1 2026, down 25.94% YoY from $21.2 million in Q1 2025, and up 1862.5% on a QoQ basis from $800000.0 in Q4 2025.
Insulet (PODD) Share-based Compensation (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Share-based Compensation data on file, last reported at $15.7 million in Q1 2026.
- Quarterly Share-based Compensation fell 25.94% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (down 76.14% YoY) and the FY2025 annual result came in at $25.9 million, down 62.63% from the prior year.
- Share-based Compensation rose to $15.7 million in Q1 2026, from $800000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $69.0 million in Q4 2024 to a low of -$30.9 million in Q3 2024.
- A 5-year average of $9.7 million and a median of $9.0 million in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation slumped 300.89% — and 2024, when it soared 1646.67%.
- Tracing PODD's Share-based Compensation over 5 years: stood at $11.2 million in 2022, then tumbled by 300.89% to -$22.5 million in 2023, then jumped by 406.67% to $69.0 million in 2024, then sank by 98.84% to $800000.0 in 2025, then jumped by 1862.5% to $15.7 million in 2026.
- The last three Share-based Compensation figures came in at $15.7 million (Q1 2026), $800000.0 (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn | 19.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.60 Mn |
| Jun 30, 2026 | 19.60 Mn |
| Mar 31, 2026 | 15.70 Mn |
| Mar 31, 2026 | 15.70 Mn |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Mar 31, 2025 | 21.20 Mn |
| Dec 31, 2024 | 69.00 Mn |
| Dec 31, 2024 | 69.00 Mn |
| Sep 30, 2024 | -30.90 Mn |
| Sep 30, 2024 | -30.90 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |